Bridging Integrator 2 (BIN2) (Middle Region) Peptide
BIN2
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all BIN2 products
- BIN2 (Bridging Integrator 2 (BIN2))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- LEVSPNPEPP EKPVRTPEAK ENENIHNQNP EELCTSPTLM TSQVASEPGE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- BIN2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BIN2 (Bridging Integrator 2 (BIN2))
- Background
-
Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis.
Alias Symbols: BRAP-1
Protein Size: 565 - Gene ID
- 51411
- NCBI Accession
- NM_001290007, NP_001276936
- UniProt
- Q9UBW5
-
You are here:
